[1-(Isoquinolin-5-yl)-5-methyl-1H-pyrazole-4-carbonyl]guanidine hydrochloride | 241799-30-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: [1-(Isoquinolin-5-yl)-5-methyl-1H-pyrazole-4-carbonyl]guanidine hydrochloride
• 英文别名: N-carbamimidoyl-1-isoquinolin-5-yl-5-methylpyrazole-4-carboxamide;hydrochloride
• CAS: 241799-30-4
• 化学式: C₁₅H₁₄N₆O*ClH
• 分子量: 330.777
• InChiKey: ULIOMQHCDHGRPG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.77
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  110
• 氢给体数：
  4
• 氢受体数：
  4

文献信息

• [EN] COMPOUNDS WHICH ARE MODULATORS OF THE PPAR-TYPE RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS<br/>[FR] COMPOSES MODULATEURS DES RECEPTEURS DU TYPE PPAR ET LEUR UTILISATION DANS DES PREPARATIONS PHARMACEUTIQUES ET COSMETIQUES
  申请人：GALDERMA RES & DEV

  公开号：WO2004071504A1

  公开（公告）日：2004-08-26

  The invention relates to novel compounds which correspond to the general formula (I), their method of preparation, and their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology and in the field of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or in cosmetic compositions.

  本发明涉及与通式（I）相对应的新化合物，其制备方法以及它们在制备用于人类或兽医药物（在皮肤病学以及心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域）或化妆品中的应用。
• N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
  申请人：Pfizer Inc.

  公开号：US20030149043A1

  公开（公告）日：2003-08-07

  NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.

  NHE-1抑制剂，使用这种NHE-1抑制剂的方法以及含有这种NHE-1抑制剂的制药组合物。NHE-1抑制剂对于减少组织缺血引起的组织损伤是有用的。
• N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia
  申请人：Pfizer Products Inc.

  公开号：EP1454902A1

  公开（公告）日：2004-09-08

  This invention relates to NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.

  本发明涉及 NHE-1 抑制剂、使用这种 NHE-1 抑制剂的方法以及含有这种 NHE-1 抑制剂的药物组合物。NHE-1 抑制剂可用于减少组织缺血造成的组织损伤。
• N-[(SUBSTITUTED FIVE-MEMBERED DI- OR TRIAZA DIUNSATURATED RING)CARBONYL]GUANIDINE DERIVATIVES FOR THE TREATMENT OF ISCHEMIA
  申请人：Pfizer Products Inc.

  公开号：EP1056729B1

  公开（公告）日：2004-12-29
• COMPOUNDS WHICH ARE MODULATORS OF THE PPAR-TYPE RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
  申请人：Galderma Research & Development, S.N.C.

  公开号：EP1596853A1

  公开（公告）日：2005-11-23